Biopharmaceuticals from Plants

Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications

Volumn , Issue , 2012, Pages 59-69

  Warzecha, Heribert ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Glucocerebrosidase; Insulin; Molecular farming; Plant made pharmaceuticals; Transgenic plants

Indexed keywords

EID: 84885560292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527632909.ch4     Document Type: Chapter

References (27)

1. Walsh, G. (2010) Biopharmaceutical benchmarks 2010. Nat. Biotechnol., 28 (9), 917-924.
2. Li, H. and d'Anjou, M. (2009) Pharmacological significance of glycosylation in therapeutic proteins. Curr. Opin. Biotechnol., 20 (6), 678-684.
3. Gerngross, T.U. (2004) Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol., 22 (11), 1409-1414.
4. Wurm, F.M. (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol., 22 (11), 1393-1398.
5. Sijmons, P.C., Dekker, B.M., Schrammeijer, B., et al. (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology (N Y), 8 (3), 217-221.
6. Tzfira, T. and Citovsky, V. (2006) Agrobacterium-mediated genetic transformation of plants: biology and biotechnology. Curr. Opin. Biotechnol., 17 (2), 147-154.
7. Bock, R. andWarzecha, H. (2010) Solar-powered factories for new vaccines and antibiotics. Trends Biotechnol., 28 (5), 246-252.
8. Oey, M., Lohse, M., Scharff, L.B., et al. (2009) Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc. Natl. Acad. Sci. U.S.A., 106 (16), 6579-6584.
9. Pogue, G.P., Lindbo, J.A., Garger, S.J., et al. (2002) Making an ally from an enemy: plant virology and the new agriculture. Annu. Rev. Phytopathol., 40, 45-74.
10. Marillonnet, S., Thoeringer, C., Kandzia, R., et al. (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol., 23 (6), 718-723.
11. Marillonnet, S., Giritch, A., Gils, M., et al. (2004) In plant engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl. Acad. Sci. U.S.A., 101 (18), 6852-6857.
12. de Jaeger, G., Scheffer, S., Jacobs, A., et al. (2002) Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat. Biotechnol., 20 (12), 1265-1268.
13. Drakakaki, G., Marcel, S., Arcalis, E., et al. (2006) The intracellular fate of a recombinant protein is tissue dependent. Plant Physiol., 141 (2), 578-586.
14. Hellwig, S., Drossard, J., Twyman, R.M., et al. (2004) Plant cell cultures for the production of recombinant proteins. Nat. Biotechnol., 22 (11), 1415-1422.
15. N.N. (2006) News in brief. Nat. Biotech., 24 (3), 233-234.
16. Grabowski, G.A. (1993) Gaucher disease. Enzymology, genetics, and treatment. Adv. Hum. Genet., 21, 377-441.
17. Friedman, B., Vaddi, K., Preston, C., et al. (1999) A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease. Blood, 93 (9), 2807-2816.
18. Shaaltiel, Y., Bartfeld, D., Hashmueli, S., et al. (2007) Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotech. J, 5 (5), 579-590.
19. Aviezer, D., Brill-Almon, E., Shaaltiel, Y., et al. (2009) A plant-derived recombinant human glucocerebrosidase enzyme-a preclinical and phase I investigation. PLoS ONE, 4 (3), e4792.
20. Hollak, C.E.M., Vom Dahl, S., Aerts, J.M.F.G., et al. (2010) Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease. Blood Cells Mol. Dis., 44 (1), 41-47.
21. Hollak, C.E.M. (2011) Short-term withdrawal from imiglucerase: What can we learn from it? Blood Cells Mol. Dis., 46 (1), 105-106.
22. Boothe, J., Nykiforuk, C., Shen, Y., et al. (2010) Seed-based expression systems for plant molecular farming. Plant Biotechnol. J., 8 (5), 588-606.
23. Nykiforuk, C.L., Shen, Y., Murray, E.W., et al. (2011) Expression and recovery of biologically active recombinant Apolipoprotein AI(Milano) from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnol.J., 9 (2), 250-263.
24. Strauss, S. (2010) BARDA funds vaccine makers aiming to phase out eggs. Nat. Biotech., 28 (12), 1227-1228.
25. d'Aoust, M.A., Couture, M.M., Charland, N., et al. (2010) The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J., 8 (5), 607-619.
26. Pogue, G.P., Vojdani, F., Palmer, K.E., et al. (2010) Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol. J., 8 (5), 638-654.
27. Thiel, K.A. (2004) Biomanufacturing, from bust to boom... to bubble? Nat. Biotechnol., 22 (11), 1365-1372.